Unpublished conference/Abstract (Scientific congresses and symposiums)
Efficacy and safety of a second JAK inhibitor in Ulcerative Colitis : J2J multicenter cohort
Osty, Mathilde; Altwegg, Romain; Serrero, Melanie et al.
202520th Congress of European Crohn's and Colitis Organisation
Peer reviewed
 

Files


Full Text
J2J.docx
Author preprint (23.96 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Gastroenterology & hepatology
Author, co-author :
Osty, Mathilde
Altwegg, Romain
Serrero, Melanie
Benezech, Alban
Cadiot, Guillaume
Vuitton, Lucine
Wampach, Anne
Nancy, Stephane
Buisson, Anthony
Le Berre, Catherine
Rouillon, Clea
Gilletta, Cyrielle
Goutorbe, Felix
Fumery, Mathurin
Hammoudi, Nassim
Caillo, Ludovic
Vidon, Mathias
Arab, Mohamed
Sickersen, Gaelle
Cavicchi, Maryan Nicolas
Vieujean, Sophie  ;  Université de Liège - ULiège > Département des sciences cliniques > Hépato-gastroentérologie ; Université de Liège - ULiège > GIGA ; Centre Hospitalier Universitaire de Liège - CHU > > Service de gastroentérologie, hépatologie, onco. digestive
Wils, Pauline
Caron, Bénédicte
Amiot, Aurélien
Nuzzo, Alexandre
Laharie, David
Kirchgesner, Julien
Uzzan, Mathieu
More authors (18 more) Less
Language :
English
Title :
Efficacy and safety of a second JAK inhibitor in Ulcerative Colitis : J2J multicenter cohort
Publication date :
February 2025
Event name :
20th Congress of European Crohn's and Colitis Organisation
Event place :
Berlin, Germany
Event date :
February 19-22, 2025
By request :
Yes
Audience :
International
Peer reviewed :
Peer reviewed
Available on ORBi :
since 25 December 2024

Statistics


Number of views
5 (1 by ULiège)
Number of downloads
0 (0 by ULiège)

Bibliography


Similar publications



Contact ORBi